FindTrial
Sign In

Diagnosis of blistering skin diseaes

A prospective study of serrated pattern analysis by direct immunofluorescence microscopy in subepidermal autoimmune blistering diseases - SPARSH

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012881
Enrollment
64
Registered
2018-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Clinically suspected to have subepidermal autoimmune blistering diseases

Interventions

None listed

Sponsors

Dr Sukriti Arora
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender aged 18 years or more suspected of having subepidermal autoimmune blistering diseases (sAIBDs) clinically and undergoing biopsy for direct immunofluorescence (DIF)

Exclusion criteria

Exclusion criteria: Those who are not willing to give consent

Design outcomes

Primary

MeasureTime frame
Assessing utility of serrated pattern analysis by direct immunofluorescence microscopy in the diagnosis of subepidermal autoimmune blisteing diseases (sAIBDs)Timepoint: 1 year 9 months—

Secondary

MeasureTime frame
To compare results of serrated pattern analysis of direct immunofluorescence (DIF) with that of indirect immunofluorescence(IIF) using salt split skinTimepoint: 1 year 9 months—

Countries

India

Contacts

Public ContactRaghavendra Rao

Kasturba Medical College, Manipal

jenny.rao@manipal.edu9845292640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026